Previous studies showed that RANTES played a fundamental role in the trafficking and activation of leukocytes in arthritis establishment [46,50] and that the use of RANTES antagonists could lead to reduced joint inflammation [51,52]. The gene discussed is CCL5; the disease is arthritic joint disease.